OGEN Gross Margin

The Gross Margin of Oragenics Inc (OGEN) is 60.64%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

OGEN Gross Margin - Historical Value

Date	Value
2024-12-31	60.64%

OGEN Gross Margin - Peers Comparison

Ticker	Name	Value
CYCC	Cyclacel Pharmaceuticals Inc	40.66%
FWP	Forward Pharma A/S	98.00%
OCUP	Ocuphire Pharma Inc	87.50%
CLRB	Cellectar Biosciences Inc	7775.20%
CYTH	Cyclo Therapeutics Inc	90.85%
ABIO	ARCA Biopharma Inc	7775.20%
APM	Aptorum Group Ltd	2.45%
PMCB	PharmaCyte Biotech Inc	-
SNGX	Soligenix Inc	-
BIOC	Biocept Inc	-9.99%
CYTR	CytRx Corp	100.00%
MBRX	Moleculin Biotech Inc	7775.20%
EDT.TO	Spectral Medical Inc	44.53%
ONVO	Organovo Holdings Inc	85.00%
MYMX	Mymetics Corp	-40.19%
SBFM	Sunshine Biopharma Inc	30.60%
LMNL	Liminal BioSciences Inc	38.55%
BBI	Brickell Biotech Inc	56.79%
RZLT	Rezolute Inc	7775.20%
AIM	AIM ImmunoTech Inc	79.21%
ARMP	Armata Pharmaceuticals Inc	7775.20%
IPIX	Innovation Pharmaceuticals Inc	100.00%
SBM.V	Sirona Biochem Corp	92.56%
CAPR	Capricor Therapeutics Inc	7775.20%
CLCS	Cell Source Inc	7775.20%
GALT	Galectin Therapeutics Inc	7775.20%